Reprint

PI3K/AKT/mTOR Signaling Network in Human Health and Diseases

Edited by
January 2025
320 pages
  • ISBN 978-3-7258-2774-9 (Hardback)
  • ISBN 978-3-7258-2773-2 (PDF)

This is a Reprint of the Special Issue PI3K/AKT/mTOR Signaling Network in Human Health and Diseases that was published in

Biology & Life Sciences
Summary

In recent years, researchers have shown a special interest in the role of signaling pathways as disease molecular targets and capitalized on such pathways to derive natural products, biologics, and synthetic scaffold-based prevention and treatments. These can lead to naturally available, efficacious, low-cost, and minimally toxic long-term therapies for human diseases. This Special Issue of Cells comprises an array of literature reviews, original communications, and studies on the roles of the PI3K/AKT/mTOR and associated pathways in a diversity of pathways using in vitro cell-based assays and preclinical animal models. The authors of the papers also explore technologies designed to improve the bioavailability and delivery of certain compounds. In lieu of ongoing research on a variety of human disorders, the wealth of information published in this Special Issue can act as a springboard for the identification of novel disease targets and the development of new preventive and therapeutic modalities for the management of human diseases.

Related Books

December 2020

mTOR Signaling in Metabolism and Cancer

Biology & Life Sciences
June 2019

mTOR in Human Diseases

Biology & Life Sciences
March 2019

AMP-Activated Protein Kinase Signalling

Biology & Life Sciences
June 2021

P38 Signaling Pathway

Biology & Life Sciences
October 2024

Feature Paper in Physiology and Pathology

Medicine & Pharmacology

The recommendations have been generated using an AI system.